Recently men with advanced prostate cancer have found that their insurance companies have been dictating what drugs they can get instead of their doctor making the best decision for them. At Malecare we have seen that when a man with metastatic castrate resistant prostate cancer (mCRPC) has finished taking chemotherapy they have been steered by [...]
I received an email from a lady from Australia that I though would be informative to share. It discusses genetic links and risk factors for hormonally related (including prostate) cancers: HER EMAIL TO ME Hi there :) I hope you don't mind me emailing you? I'm a lady from Australia and have 3 uncles with [...]
OK, I give up, what’s a man to eat? Red meat and dairy are terrible for us, we all already know that, but now eggs and poultry are on the do not eat list. Pretty much this leaves us with vegetables only. I know, a vegetarian or vegan diet is understood to be best, but [...]
There are a number of funds available to assist men with their treatment co-pays and to help cover travel for treatments. These funds receive their financial support from the drug companies (pharama) which make voluntary contributions. Within the overarching fund there are many disease specific funds that supply co-pay and or travel support for individuals. [...]
Enzalutamide (Xtandi) monotherapy induced striking declines in prostate-specific antigen (PSA) in a majority of patients with hormone-naive prostate cancer in a phase II trial, and this oral agent appears to have little effect on bone mineral density. If these findings are confirmed in a phase III trial, then enzalutamide may be an alternative to androgen [...]